greeksoup/ stock research

Progyny (PGNY) Q2 FY2026 earnings: revenue $351 million, up 5.3% on the year

Progyny, Inc. (PGNY) reported revenue of $351 million for Q2 FY2026, the quarter ended 30 June 2026, up 5.3% on the same quarter a year earlier. Net income was $28 million, up 63.9% on the year, and diluted earnings per share $0.34. The figures are the company's own, from the 10-Q it filed with the SEC on 7 August 2026.

Revenue$351 millionup 5.3%
Net income$28 millionup 63.9%
Diluted EPS$0.34
QuarterQ2 FY2026ended 30 June 2026

The quarter, against the one before and a year earlier

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Revenue351329333+5.3%
Cost of revenue261245254+2.9%
Gross profit89.383.179.0+13.1%
Gross margin25.5%25.3%23.7%
Research and development3.32.82.3+43.5%
Operating income40.035.424.4+64.2%
Operating margin11.4%10.8%7.3%
Pre-tax income41.136.927.1+51.9%
Income tax13.112.710.0+31.3%
Effective tax rate31.8%34.3%36.8%
Net income28.124.217.1+63.9%
Net margin8.0%7.4%5.1%
Diluted EPS$0.34$0.29$0.19+78.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Operating cash flow50.445.955.5-9.2%
Capital expenditure6.26.35.3+18.0%
Free cash flow44.239.650.2-12.0%
Free cash flow margin12.6%12.1%15.1%
Cash from investing3.696.6-29.9n/a
Cash from financing-32.9-123-2.3n/a
Depreciation and amortisation1.61.51.2+34.7%
Share-based compensation20.519.732.4-36.8%
Buybacks30.01190.0n/a
Diluted shares, weighted82m85m90m-8.4%
Shares outstanding at period end77m78m86m-9.9%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ2 FY2026Q1 FY2026Q2 FY2025Change on the year
Shareholders' equity453439515-12.0%
Debt0.00.00.0n/a
Operating lease liabilities22.523.325.5-11.8%
Other liabilities240236220+8.9%
Total liabilities and equity716698761-5.9%
Fixed assets42.035.719.9+110.6%
Goodwill19.919.920.0-0.6%
Intangible assets5.76.06.6-13.5%
Investments84.393.5173-51.2%
Cash and equivalents153132133+15.2%
Receivables257264272-5.3%
Other assets154148137+11.9%
Total assets716698761-5.9%

Questions

What was Progyny's revenue in Q2 FY2026?

Progyny (PGNY) reported revenue of $351 million for Q2 FY2026, the quarter ended 30 June 2026, up 5.3% on the same quarter a year earlier.

How much did Progyny earn in Q2 FY2026?

Net income for Q2 FY2026 was $28 million, up 63.9% on the year, and diluted earnings per share $0.34.

When did Progyny report Q2 FY2026 results?

Progyny filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 7 August 2026.

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Revenue281270278304287298324333313318329351
Cost of revenue218213216236227235248254241242245261
Gross profit62.656.962.468.359.263.475.879.072.876.983.189.3
Gross margin22%21%22%22%21%21%23%24%23%24%25%25%
R&Dn/an/an/an/an/an/a1.52.32.63.12.83.3
Operating income18.213.818.520.712.515.824.224.421.515.235.440.0
Operating margin6%5%7%7%4%5%7%7%7%5%11%11%
Pre-tax income20.916.322.525.118.017.726.527.124.017.936.941.1
Tax rate24%17%25%34%42%40%43%37%42%30%34%32%
Net income15.913.516.916.510.410.515.117.113.912.524.228.1
Net margin6%5%6%5%4%4%5%5%4%4%7%8%
Diluted EPS$0.16$0.13$0.17$0.17$0.11$0.12$0.17$0.19$0.15$0.14$0.29$0.34
Operating cash flow54.237.725.756.744.552.249.855.550.754.245.950.4
Capital expenditure1.00.70.80.91.81.92.85.34.75.66.36.2
Free cash flow53.237.024.955.842.750.347.050.246.048.639.644.2
Buybacks0.00.023.816061.555.10.00.00.081.711930.0
Shares outstanding96m96m96m91m88m85m86m86m86m83m78m77m
Filing10-K10-K10-K10-K10-K10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read moreMoney is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 June 2026, filed 7 August 2026, accession 0001551306-26-000140: the filing on EDGAR. All of Progyny, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install